Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.

China's emergence as a second hub of pharmaceutical innovation could trigger massive changes to the global drug market, including how treatments are regulated and priced in the U.S. Why it matters: ...

The United States recently repatriated a Chinese national suspected of drug trafficking, a "first" such return in recent years, Beijing's public security ministry said on Friday. China is the primary ...